Gonzalo Castillo-Rojas

Dr. Gonzalo Castillo-Rojas

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Processes
Verified
Journal Article
Open access
PDF file
CRClaudia Ivette Rivas-Ortiz
Claudia Ivette Rivas-Ortiz
SMStephanie Euridice Morales-Guerrero
Stephanie Euridice Morales-Guerrero
SPSergio Ponce-De-León-Rosales
Sergio Ponce-De-León-Rosales
AGArmando Gamboa-Domínguez
Armando Gamboa-Domínguez
Claudia Rangel-EscareñoClaudia Rangel-Escareño
Claudia Rangel-Escareño
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
Chronic Helicobacter pylori infection produces several lesions in the human stomach, which can progress to chronic atrophic gastritis and gastric cancer. To date, there is very little information on gene expression in chronic atrophic gastritis and its relationship with progression to gastric cancer. In this study, we performed a gene expression analysis during chronic atrophic gastritis in order to identify possible biomarkers that allow an early diagnosis of gastric cancer. We studied biopsies from patients with chronic atrophic gastritis and gastric cancer. The biopsies were analyzed by a gene expression microarray and corroborated by qPCR and validated through immunohistochemistry. Our results revealed that gene expression profiles in patients with chronic atrophic gastritis showed molecular changes of the gastric mucosa, leading to gastric cancer. The gene expression profiles of CLDN1, CLDN7, OLFM4, C-MYC and MMP9 were more notable from the chronic atrophic gastritis. The gene expression patterns observed in this study allowed the identification of CLDN1 and MMP9 proteins as promising biomarkers of early stages of gastric cancer development.

17 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
YVYolanda López- Vidal
Yolanda López- Vidal
JCJuan José Calva
Juan José Calva
RARosa Isabel Amieva-Fernández
Rosa Isabel Amieva-Fernández
CMCristina Majalca-Martínez
Cristina Majalca-Martínez
GÁGerardo Ávila-Vargas
Gerardo Ávila-Vargas
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
An efficacious treatment of H. pylori infection is cornerstone for the global control of the diseases caused by this bacterium. Continuous epidemiologic surveillance of susceptibility of H. pylori to the antibiotics recommended for its eradication is highly recommended. This study aimed to determine the antimicrobial susceptibility pattern of 651 isolates from five different collections isolated between 1996 to 2008 in México City. The susceptibility profile of H. pylori isolates was determined by the E-test strips for each antibiotic (amoxicillin, clarithromycin, metronidazole, and tetracycline). Antimicrobial susceptibility testing showed a very high proportion of H pylori strains susceptible to amoxicillin, clarithromycin, and tetracycline (94.5%, 95%, and 99.5 %, respectively). In contrast, a high proportion (95%) of isolates was resistant to metronidazole. Notably, the proportion of susceptible/resistant strains to the 4 antibiotics over 5 consecutive time periods remained stable over time. Despite a wide use of amoxicillin and clarithromycin in the general population, the H pylori high susceptibility to these 2 antibiotics has been preserved during more than a decade. The high prevalence of resistance to metronidazole in H. pylori strains in our population compromises its use in the empirical treatment of H. pylori infection.

1 September 2026 in Water Science & Technology
Verified
Journal Article
Open access
NVNallely Vázquez-Salvador
Nallely Vázquez-Salvador
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
RARosa Isabel Amieva-Fernández
Rosa Isabel Amieva-Fernández
YVYolanda López- Vidal
Yolanda López- Vidal
HRHoracio Riojas
Horacio Riojas
MMMarisa Mazari-Hiriart
Marisa Mazari-Hiriart
Graphical abstract illustrating the dynamics of wastewater that is used in the Mezquital Valley. The diagram shows the water types analyzed through bacterial determination and susceptibility tests, highlighting the presence of extended-spectrum beta-lactamase-producing E. coli. Antibiotic-resistant bacteria (ARB) in water sources constitute an important public health challenge; consequently, monitoring is necessary to mitigate their dissemination. We describe the resistance profile of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in two zones from the Mezquital Valley, Hidalgo, where wastewater is reused for irrigation. Three sampling campaigns were conducted between 2016 and 2017 in this area. Household water and irrigation samples were processed through membrane filtration and cultured on antibiotic-supplemented media (n = 105). Presumptive E. coli colonies were isolated, after which we performed susceptibility profiles and identification using the MicroScan system. The presence of E. coli was confirmed in 96.6% of isolates, and 82.4% of them were ESBL producers. Household water from Zone A showed higher ESBL-E. coli counts compared with Zone B (p = 0.0247), likely due to its proximity to wastewater canals. Similar profiles between household water and wastewater isolates were observed (p = 0.81). Multidrug resistance (MDR) was detected in domestic and wastewater isolates. No resistance was determined for groundwater. Household water with the presence of ARB suggests wastewater contact with water supplied for human use. This case reinforces the need to meet standards and use risk assessments to mitigate negative effects of wastewater on the environment, human populations, and animals.

1 November 2026 in Gut Microbes
Verified
Journal Article
Open access
RARene Arredondo-Hernandez
Rene Arredondo-Hernandez
POPatricia Orduña
Patricia Orduña
ASAlejandro Schcolnik-Cabrera
Alejandro Schcolnik-Cabrera
GCGonzalo Castillo-Rojas
Gonzalo Castillo-Rojas
MLMariana López-Filloy
Mariana López-Filloy
YVYolanda López- Vidal
Yolanda López- Vidal